Alpha-v beta-3

αVβ3 is a type of integrin that is a receptor for vitronectin. It consists of two components, integrin alpha V and integrin beta 3 (CD61), and is expressed by platelets. Furthermore, it is a receptor for phagocytosis on macrophages or dendritic cells. αVβ3 is a type of integrin that is a receptor for vitronectin. It consists of two components, integrin alpha V and integrin beta 3 (CD61), and is expressed by platelets. Furthermore, it is a receptor for phagocytosis on macrophages or dendritic cells. Integrin αVβ3 is potential drug target because abnormal expression of v3 is linked to the development and progression of various diseases. In cancer and other diseases, its role in angiogenesis is directly responsible to providing blood supply to problematic overgrowths. Inhibitors like etaracizumab may be used as antiangiogenics. One novel protein (ProAgio) has been designed to bind at an unusual site, and then induces apoptosis by recruiting caspase 8. It is designed by mutating domain 1 of CD2 (D1-CD2), which naturally binds weakly to the receptor. Fibronectin domain 10 contains the RGD motif that αVβ3 recognizes. A high-affinity, pure antagonist mutant has been discovered for this protein. The core vtprgdwne motif is the subject of a Fold.it puzzle.